Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors.

Rank MA, Oslie CL, Krogman JL, Park MA, Li JT.

Allergy Asthma Proc. 2008 Jul-Aug;29(4):400-5. doi: 10.2500/aap.2008.29.3141.

PMID:
18702889
[PubMed - indexed for MEDLINE]
2.

Allergen immunotherapy and asthma: efficacy, safety, and other considerations.

Cox L.

Allergy Asthma Proc. 2008 Nov-Dec;29(6):580-9. doi: 10.2500/aap.2008.29.3162. Review.

PMID:
19173785
[PubMed - indexed for MEDLINE]
3.

Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.

Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G.

J Allergy Clin Immunol. 2010 Mar;125(3):569-74, 574.e1-574.e7. doi: 10.1016/j.jaci.2009.10.060. Epub 2010 Feb 7. Review.

PMID:
20144472
[PubMed - indexed for MEDLINE]
4.

Systemic reactions to allergen immunotherapy: a review of the literature.

Nettis E, Giordano D, Ferrannini A, Tursi A.

Immunopharmacol Immunotoxicol. 2003 Feb;25(1):1-11. Review.

PMID:
12675195
[PubMed - indexed for MEDLINE]
5.

The safety of allergen immunotherapy: a literature review.

Cook PR, Farias C.

Ear Nose Throat J. 1998 May;77(5):378-9, 383-8. Review.

PMID:
9615518
[PubMed - indexed for MEDLINE]
6.

Immunotherapy safety: what have we learned from surveillance surveys?

Kannan JA, Epstein TG.

Curr Allergy Asthma Rep. 2013 Aug;13(4):381-8. doi: 10.1007/s11882-013-0353-0. Review.

PMID:
23636820
[PubMed - indexed for MEDLINE]
7.

Improving the safety of immunotherapy.

Rank MA, Bernstein DI.

J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):131-5. doi: 10.1016/j.jaip.2013.09.017. Epub 2013 Dec 19. Review.

PMID:
24607038
[PubMed - indexed for MEDLINE]
8.

Local reactions from subcutaneous allergen immunotherapy.

Coop CA.

Immunotherapy. 2013 Dec;5(12):1339-45. doi: 10.2217/imt.13.143. Review.

PMID:
24283844
[PubMed - indexed for MEDLINE]
9.

Risk management in allergen immunotherapy.

Greineder DK.

J Allergy Clin Immunol. 1996 Dec;98(6 Pt 3):S330-4. Review.

PMID:
8977545
[PubMed - indexed for MEDLINE]
10.

Systemic reactions and fatalities associated with allergen immunotherapy.

Lockey RF, Nicoara-Kasti GL, Theodoropoulos DS, Bukantz SC.

Ann Allergy Asthma Immunol. 2001 Jul;87(1 Suppl 1):47-55. Review.

PMID:
11476476
[PubMed - indexed for MEDLINE]
11.

Reducing and managing systemic reactions to immunotherapy.

Ravi A, Rank MA.

Curr Opin Allergy Clin Immunol. 2013 Dec;13(6):651-5. doi: 10.1097/ACI.0b013e328364c876. Review.

PMID:
24145315
[PubMed - indexed for MEDLINE]
12.

Issues in stinging insect allergy immunotherapy: a review.

Finegold I.

Curr Opin Allergy Clin Immunol. 2008 Aug;8(4):343-7. doi: 10.1097/ACI.0b013e328306a007. Review.

PMID:
18596592
[PubMed - indexed for MEDLINE]
13.

Insect sting allergy and venom immunotherapy.

Golden DB.

Ann Allergy Asthma Immunol. 2006 Feb;96(2 Suppl 1):S16-21. Review.

PMID:
16496507
[PubMed - indexed for MEDLINE]
14.

Anaphylactic reactions during immunotherapy.

Rezvani M, Bernstein DI.

Immunol Allergy Clin North Am. 2007 May;27(2):295-307, viii. Review.

PMID:
17493504
[PubMed - indexed for MEDLINE]
15.

Adverse reactions associated with skin testing and immunotherapy.

Lockey RF.

Allergy Proc. 1995 Nov-Dec;16(6):293-6. Review.

PMID:
8747313
[PubMed - indexed for MEDLINE]
16.

Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.

Bukantz SC, Bagg AS, Lockey RF.

Clin Allergy Immunol. 2008;21:455-68. Review. No abstract available.

PMID:
18828523
[PubMed - indexed for MEDLINE]
17.

Risk factors for systemic reactions to allergen immunotherapy.

Iglesias-Cadarso A, Hernández-Weigand P.

Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):579-85. doi: 10.1097/ACI.0b013e32834c229e. Review.

PMID:
21971329
[PubMed - indexed for MEDLINE]
18.

Minimising the risks of allergen-specific injection immunotherapy.

Malling HJ.

Drug Saf. 2000 Oct;23(4):323-32. Review.

PMID:
11051219
[PubMed - indexed for MEDLINE]
19.

Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?

Lang DM.

Curr Allergy Asthma Rep. 2008 Mar;8(1):37-44. Review.

PMID:
18377773
[PubMed - indexed for MEDLINE]
20.

Safe allergen immunotherapy. The correct allergen, the appropriate patient, the adequate dose.

Schoenwetter WF.

Postgrad Med. 1996 Aug;100(2):123-6, 131-5. Review.

PMID:
8700812
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk